289 related articles for article (PubMed ID: 24552860)
21. Mother-to-infant transmission of hepatitis B virus: challenges and perspectives.
Shih YF; Liu CJ
Hepatol Int; 2017 Nov; 11(6):481-484. PubMed ID: 29064028
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis B: Treatment to prevent perinatal transmission.
Tran TT
Clin Obstet Gynecol; 2012 Jun; 55(2):541-9. PubMed ID: 22510637
[TBL] [Abstract][Full Text] [Related]
23. [Efficacy and safety of telbivudine in pregnant women to prevent perinatal transmission of hepatitis B virus].
Han GR; Jiang HX; Wang GJ; Yue X; Wang CM; Kan NY; Wu MM
Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):201-5. PubMed ID: 22475140
[TBL] [Abstract][Full Text] [Related]
24. Maternal antiviral treatment safeguards infants from hepatitis B transmission in contingencies of delayed immunoprophylaxis.
Li Y; Wang J; Yu Y; Qiu C; Li Z; Ling Q; Zhang G; Li L; Gong Y; Lu Q; Cao L; Gu T; Wang X; Zhang M; Zhang Q; Zhang H; Xu B; Shao L; Pu Y; Zhang W
Liver Int; 2020 Oct; 40(10):2377-2384. PubMed ID: 32304160
[TBL] [Abstract][Full Text] [Related]
25. Comparison of telbivudine versus lamivudine in interrupting perinatal transmission of hepatitis B virus.
Yu MM; Jiang Q; Ji Y; Wu KH; Ju LL; Tang X; Yang YF
J Clin Virol; 2014 Sep; 61(1):55-60. PubMed ID: 24994007
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis B - Vertical transmission and the prevention of mother-to-child transmission.
Cheung KW; Lao TT
Best Pract Res Clin Obstet Gynaecol; 2020 Oct; 68():78-88. PubMed ID: 32249130
[TBL] [Abstract][Full Text] [Related]
27. Safety and efficacy of lamivudine or telbivudine started in early pregnancy for mothers with active chronic hepatitis B.
He T; Bai Y; Cai H; Ou X; Liu M; Yi W; Jia J
Hepatol Int; 2018 Mar; 12(2):118-125. PubMed ID: 29344772
[TBL] [Abstract][Full Text] [Related]
28. Prevention of perinatal hepatitis B transmission in Haimen City, China: Results of a community public health initiative.
Evans AA; Cohen C; Huang P; Qian L; London WT; Block JM; Chen G
Vaccine; 2015 Jun; 33(26):3010-5. PubMed ID: 25698491
[TBL] [Abstract][Full Text] [Related]
29. Serological positive markers of hepatitis B virus in femoral venous blood or umbilical cord blood should not be evidence of in-utero infection among neonates.
Zhang L; Gui XE; Wang B; Fan JY; Cao Q; Mullane K; Liang XL
BMC Infect Dis; 2016 Aug; 16(1):408. PubMed ID: 27515176
[TBL] [Abstract][Full Text] [Related]
30. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study.
Xu WM; Cui YT; Wang L; Yang H; Liang ZQ; Li XM; Zhang SL; Qiao FY; Campbell F; Chang CN; Gardner S; Atkins M
J Viral Hepat; 2009 Feb; 16(2):94-103. PubMed ID: 19175878
[TBL] [Abstract][Full Text] [Related]
31. Prevention of mother-to-child transmission of hepatitis B virus and hepatitis C virus.
Gentile I; Zappulo E; Buonomo AR; Borgia G
Expert Rev Anti Infect Ther; 2014 Jul; 12(7):775-82. PubMed ID: 24840817
[TBL] [Abstract][Full Text] [Related]
32. Mother-to-child transmission of hepatitis B: Examining viral cut-offs, maternal HBsAg serology and infant testing.
Thilakanathan C; Wark G; Maley M; Davison S; Lawler J; Lee A; Shackel N; Nguyen V; Jackson K; Glass A; Locarnini SA; Levy MT
Liver Int; 2018 Jul; 38(7):1212-1219. PubMed ID: 29532580
[TBL] [Abstract][Full Text] [Related]
33. Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load.
Pan CQ; Duan Z; Dai E; Zhang S; Han G; Wang Y; Zhang H; Zou H; Zhu B; Zhao W; Jiang H;
N Engl J Med; 2016 Jun; 374(24):2324-34. PubMed ID: 27305192
[TBL] [Abstract][Full Text] [Related]
34. Prophylaxis of vertical HBV infection.
Pawlowska M; Pniewska A; Pilarczyk M; Kozielewicz D; Domagalski K
Expert Opin Drug Saf; 2016 Oct; 15(10):1361-8. PubMed ID: 27402246
[TBL] [Abstract][Full Text] [Related]
35. Eradicating hepatitis B virus: The critical role of preventing perinatal transmission.
Stevens CE; Toy P; Kamili S; Taylor PE; Tong MJ; Xia GL; Vyas GN
Biologicals; 2017 Nov; 50():3-19. PubMed ID: 28870397
[TBL] [Abstract][Full Text] [Related]
36. Telbivudine prevents vertical transmission from HBeAg-positive women with chronic hepatitis B.
Pan CQ; Han GR; Jiang HX; Zhao W; Cao MK; Wang CM; Yue X; Wang GJ
Clin Gastroenterol Hepatol; 2012 May; 10(5):520-6. PubMed ID: 22343511
[TBL] [Abstract][Full Text] [Related]
37. Risk factors associated with immunoprophylaxis failure against mother to child transmission of hepatitis B virus and hepatitis B vaccination status in Yunnan province, China.
Kang W; Ding Z; Shen L; Zhao Z; Huang G; Zhang J; Xiong Q; Zhang S; Zhang S; Wang F
Vaccine; 2014 Jun; 32(27):3362-6. PubMed ID: 24793939
[TBL] [Abstract][Full Text] [Related]
38. Factors associated with vaccine failure and vertical transmission of hepatitis B among a cohort of Canadian mothers and infants.
Singh AE; Plitt SS; Osiowy C; Surynicz K; Kouadjo E; Preiksaitis J; Lee B
J Viral Hepat; 2011 Jul; 18(7):468-73. PubMed ID: 20546502
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis B virus infection.
Chang MH
Semin Fetal Neonatal Med; 2007 Jun; 12(3):160-7. PubMed ID: 17336170
[TBL] [Abstract][Full Text] [Related]
40. Identification of risk factors associated with immunoprophylaxis failure to prevent the vertical transmission of hepatitis B virus.
Yin Y; Wu L; Zhang J; Zhou J; Zhang P; Hou H
J Infect; 2013 May; 66(5):447-52. PubMed ID: 23286968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
